The implantable miniature telescope (IMT) is the first surgical intervention approved for patients with end-stage AMD. It was approved by the U.S. Food and Drug Administration in July 2010. This telescope implant is an intraocular visual prosthetic device, which is inserted into the lens capsule during cataract extraction. The power of this miniature telescope helps to magnify images two to three times their original size with the goal of improving the central vision in one eye of patients with moderate to profound visual impairment. The non-implanted eye continues to see with peripheral vision, while the eye with the telescope takes on detailed central vision. Patients with implanted miniature telescope also need therapy to help re-train their brain to use each eye differently.
Due to the COVID-19 pandemic, the global Implantable Miniature Telescope market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Implantable Miniature Telescope market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Implantable Miniature Telescope landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Normal accounting for % of the Implantable Miniature Telescope global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Implantable Miniature Telescope include Centra Sight, Vision Aware, VisionCare Ophthalmic Technologies and Johns Hopkings Medicine, etc. In terms of revenue, the global 3 largest players have a % market share of Implantable Miniature Telescope in 2021.
This report focuses on Implantable Miniature Telescope volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Implantable Miniature Telescope market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Implantable Miniature Telescope Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Normal
Speical
Segment by Application
Hospitals
Ophthalmic Clinics
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Centra Sight
Vision Aware
VisionCare Ophthalmic Technologies
Johns Hopkings Medicine